Understanding diabetes caused by steroids in lupus patients
Steroid-induced Diabetes Mellitus in Systemic Lupus Erythematosus (SLE) Patients
This study looks at how often diabetes caused by steroids happens in lupus patients and what factors might increase the risk.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Assiut) |
| Trial ID | NCT04024306 on ClinicalTrials.gov |
What this trial studies
This observational study aims to determine how common steroid-induced diabetes mellitus (SDM) is among patients with systemic lupus erythematosus (SLE) and to identify the risk factors associated with its development. A total of 120 SLE patients receiving corticosteroid therapy will be recruited from the SLE and Rheumatology Clinic. Participants will undergo a thorough medical history review, clinical examination, and laboratory tests to assess their blood glucose levels and other relevant health indicators. The study will include both new and existing cases of SDM among these patients.
Who should consider this trial
Good fit: Ideal candidates for this study are SLE patients aged 18-75 who are currently receiving corticosteroid therapy.
Not a fit: Patients with SLE who are not on corticosteroid therapy or those with other types of diabetes mellitus may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help identify at-risk SLE patients and improve management strategies for steroid-induced diabetes.
How similar studies have performed: While there have been studies on diabetes in SLE patients, the specific focus on steroid-induced diabetes is less common, making this approach somewhat novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria * Both males and females * Patients aged of 18-75 years. * Clinically diagnosed as SLE patients. * Receiving corticosteroid therapy. * Prevalent cases of SDM with SLE. Exclusion criteria * SLE patients who do not receive corticosteroid therapy. * SLE patients with other types of diabetes mellitus.
Where this trial is running
Assiut
- Assiut university hospital — Assiut, Egypt (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.